About this trial
This pilot study will evaluate a comprehensive cognitive assessment approach and personalized neurocognitive telerehabilitation intervention for adults with subjective cognitive complaints (SCC). The study includes older adults with SCC and adults with Ehlers-Danlos Syndrome (EDS) and SCC. Participants will complete pre- and post-treatment assessments and receive a 6-week COG+OT telerehabilitation intervention that combines cognitive rehabilitation and occupational therapy strategies to support everyday functional cognition.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Endorsement of subjective cognitive complaints as indicated by a score ≥4 on the Healthy Brain 9 (HB9)
Community-dwelling adult aged 60 years or older, or adult aged 21 years or older with a diagnosis of Ehlers-Danlos Syndrome (EDS)
English as the primary language
Access to and ability to use a smartphone compatible with the NeuroUX platform
Disqualifiers
Diagnosis of dementia or mild cognitive impairment
Significant or unstable conditions or treatments for medical conditions that may impact cognition, such as traumatic brain injury or brain tumor
Inability to engage in study-related procedures as determined by the study team
Trial design
Single group
Treatments tested in this trial
COG+OT Telerehabilitation
BehavioralCOG+OT is a personalized telerehabilitation program that combines cognitive rehabilitation and occupational therapy. Cognitive rehabilitation sessions focus on strategies for attention, memory, organization, planning, problem solving, and executive function. Occupational therapy sessions use meaningful daily activities to support application and generalization of cognitive strategies in home- and community-based tasks. The intervention is delivered remotely over 6 weeks in 10 sessions lasting approximately 45 to 60 minutes each.
Treatment groups
Trial outcomes
Primary outcomes
Change in Everyday Cognition Scale-II (ECog-II) Score
Change in subjective cognition measured using the Everyday Cognition Scale-II (ECog-II), a self-report measure assessing perceived cognitive functioning across everyday activities, including memory, executive function, language, and attention.
Secondary outcomes
Retention Rate
Feasibility measured as the percentage of participants who complete all study sessions.
Adherence Rate
Feasibility measured as the percentage of participants completing intervention activities for each session, including functional task practice and homework.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: